Camp4 Therapeutics CAMP
NASDAQ CAMP
$4.00 +0.16 (+4.17%)
At close: Oct 2, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Price to Sales (2024 - 2026)

Updated

Camp4 Therapeutics' (CAMP) Price to Sales was 53.82 for Q2 2026, up 453.6% from 9.72 a year earlier but down 7.5% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Price to Sales (2024 - 2026) Analysis & Trends

For FY2025, Price to Sales at Camp4 Therapeutics was 53.24, up 41.8% from FY2024.

  • By year, Price to Sales came in at 37.55 in FY2024.
  • Five-year quarterly Price to Sales spans a low of 9.72 in Q2 2025 and a high of 58.21 in Q1 2026.
  • Year over year, Price to Sales has now increased in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 58.21 (Q1 2026), 53.24 (Q4 2025) and 21.52 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Camp4 Therapeutics 199.40 Mn 199.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 53.82
Mar 31, 2026 58.21
Dec 31, 2025 53.24
Sep 30, 2025 21.52
Jun 30, 2025 9.72
Mar 31, 2025 53.40
Dec 31, 2024 37.55
API Access

Camp4 Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CAMP&period=max&api_key=YOUR_API_KEY